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Abstract
Background:  Leucine-rich repeats are one of the more common modules found in proteins. The
leucine-rich repeat consensus motif is LxxLxLxxNxLxxLxxLxxLxx- where the first 11–12 residues
are highly conserved and the remainder of the repeat can vary in size Leucine-rich repeat proteins
have been subdivided into seven subfamilies, none of which include members of the epidermal
growth factor receptor or insulin receptor families despite the similarity between the 3D structure
of the L domains of the type I insulin-like growth factor receptor and some leucine-rich repeat
proteins.
Results:  Here we have used profile searches and multiple sequence alignments to identify the
repeat motif Ixx-LxIxx-Nx-Lxx-Lxx-Lxx-Lxx- in the L1 and L2 domains of the insulin receptor and
epidermal growth factor receptors. These analyses were aided by reference to the known three
dimensional structures of the insulin-like growth factor type I receptor L domains and two
members of the leucine rich repeat family, porcine ribonuclease inhibitor and internalin 1B. Pectate
lyase, another beta helix protein, can also be seen to contain the sequence motif and much of the
structural features characteristic of leucine-rich repeat proteins, despite the existence of major
insertions in some of its repeats.
Conclusion:  Multiple sequence alignments and comparisons of the 3D structures has shown that
right-handed beta helix proteins such as pectate lyase and the L domains of members of the insulin
receptor and epidermal growth factor receptor families, are members of the leucine-rich repeat
superfamily.
Background
Many proteins have a modular architecture and are com-
posed of a number of different, sometimes repeated
structural units [1,2]. The four most common modules
found in the extracellular regions of proteins are immu-
noglobulin (Ig) domains, epidermal growth factor
(EGF)-like repeats, fibronectin type 3 (Fn3) modules and
leucine-rich repeats [2]. Two of these, Fn3 modules [3–
6] and EGF-like repeats [7–10], have been identified in
members of the insulin receptor (IR) family.
There is some evidence to suggest that the L domains of
the IR and EGFR families are leucine-rich repeats. At
10–16%, leucine is the most common residue in these do-
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mains. Furthermore, the 3D structure of the L1/cys-rich/
L2 fragment of the IGF-1R showed that the L domains
were single-stranded right-handed β -helices [8] with
structural similarities to pectate lyase, a right-handed
beta helix protein [11,12] and the ribonuclease inhibitor,
a right-handed beta-alpha superhelix protein [13]. Ribo-
nuclease inhibitor (RI) is recognised as a member of the
superfamily of leucine-rich repeat proteins [14–16] while
pectate lyase is not, although similarities in the sequence
patterns and 3D structures of pectate lyase and RI have
been noted [15–17]. The IGF-1R is listed as a leucine-rich
repeat protein in the SCOP database  [http://scop.mrc-
lmb.cam.ac.uk/scop/]  but not in any of the annotated
sequence databases such as SwissProt  [http://
srs.ebi.ac.uk/]  or SMART  [http://smart.embl-heidel-
berg.de/index.shtml] [18]). Similarly, none of the other
L-domain containing proteins from the IR or EGFR fam-
ilies are listed as leucine-rich repeats in these data bases
or in a recent summary of the complete protein tyrosine
kinase family present in the human genome [19].
The superfamily of leucine-rich repeat proteins has been
subdivided into six subfamilies termed: typical, RI-like,
CC (cysteine-containing), PS (plant specific), SD22-like
and bacterial [16]. These subfamilies are characterised
by different lengths and consensus sequences of the re-
peats (Fig. 1). The bulk of the LRRs have repeats of 22–
25 amino acid residues while RI, with its alternating re-
peats of 28 to 29 residues, is considered somewhat atyp-
ical [20]. The family has been expanded further to
include the small proteoglycans, which were shown to
consist of different combinations of two types of LRRs of
21 (S-type) and 26 (T-type) amino acid residues [21]. The
LRR consensus sequence is LxxLxLxxNx-Lxx-Lxx-Lxx-
Lxx- (Fig. 1) where the first 11–12 residues are highly
conserved and the remainder of the repeat can vary in
size [16,17,21]. Some repeats have C instead of N at the
4th highly conserved position and I, V, M, F, Y, A or C at
the positions denoted by L in the above consensus (Fig.
1).
In view of this variation in sequence motifs among LRR
proteins, the sequences of the L1 and L2 domains of
members of the IR and EGFR families were re-exam-
ined. The LRR motif is difficult to detect when examining
a single sequence, but becomes more readily recognisa-
ble when multiple sequence alignments are analysed.
The identification of such conserved sequence motifs
was greatly aided by the availability of the 3D structures
of the IGF-1R L1 and L2 domains [8], pectate lyase
[11,12] and the known LRR proteins RI [13] and interna-
lin 1B [22]. The data indicate that pectate lyase and the L
domains of members of the IR and EGFR families should
be included in the expanding family of LRR proteins
Results
Preliminary analyses of the SwissProt data base using
profiles based on alignments of single (Prf1) or double
LRR repeats (Prf2) failed to score members of the IR or
EGFR families in the first 500 ranked scores. However
searches with Prf-4 (based on four tandem repeats),
ranked IR family members at positions 234
(INSR_RAT), 245 (INSR_MOUSE), 262 (IG1R_RAT)
and 478 (IG1R_HUMAN) and EGFR family members at
146 (LT23_CAEEL), 174 (EGFR_MOUSE), 448
(EGFR_HUMAN) and 457 (EGFR_CHICK). The align-
ments with the mouse, human and chick EGFRs were to
residues equivalent to 363–452 in the L2 domain of
EGFR_human. In contrast, the alignments with the oth-
er sequences were to regions in the cytoplasmic domain.
When the analyses were restricted to the receptor ecto-
domains, the alignments were to sequences in the L1 or
L2 domains. Examples are: Prf-1 with residues 1–28, Prf-
2 with residues 10–78 and Prf-4 with residues 46–153 in
the human insulin receptor. An alternative approach, us-
ing a profile generated from the alignment of the L1 do-
mains of 13 members of the IR family (see Fig. 2) was
also encouraging as it ranked four known LRR proteins
in the next 11 hits after the 26 known members of the IR
or EGFR families. These were repeats 8–14 (residues
295–450) of ESA8_TRYEQ (ranked 28th) and
ESA8_TRYBB (ranked 30th), and repeats 1–5 (residues
28–177) of TSHR_MOUSE (ranked 35th) and
TSHR_RAT (ranked 37th).
However, in both approaches, the repeating units in the
L1 and L2 domains, known from the 3D structure of IGF-
1R [8], did not align exactly with the repeating units in
the LRR proteins [20,23] or the LRR protein profiles (see
Methods). The presence of insertions in some regions of
the IR or EGFR proteins tended to confound the profile
alignments. Consequently, the nature of the repeating
sequence motifs in the L1 and L2 domains of the IR and
EGFR families were examined manually using the 3D
structure of the L1 and L2 domains of IGF-1R as a guide
to adjust the alignments obtained from the profile analy-
ses.
The consensus sequences for the six LRR protein sub-
families [16] are shown in Fig. 1. The sizes of the repeat-
ing units vary from 22–31 with eight highly conserved
positions, numbered 1 to 8 in Fig 1. Conserved position 4
usually contains N or C but sometimes S, T, P, Q or A.
The other 7 highly conserved positions are generally L
but frequently contain alternative non-polar residues
such as I, V, M, C, A, F, or Y, particularly in some LRR
subfamilies. Also included are the type S and type T
LRRs from the small proteoglycans [21]. The repeating
motifs have been arranged in Fig. 1 so that they all begin
with the 11-residue stretch LxxLxLxxNxL which containsBMC Bioinformatics (2001) 2:4 http://www.biomedcentral.com/1471-2105/2/4
the highly conserved positions 1 to 5. This motif corre-
sponds to a linear central sequence with two half turns at
either end [20]. Deletions and/or insertions, particularly
in the C-terminal portion of the repeats (after conserved
positions 5, 6, 7 and 8) account for the size differences
seen between different LRR protein members.
The repeat sequences in members of the IR family that
correspond to the six turns of the parallel beta helix of
the L1 and L2 domains of IGF-1R [8] are shown in Fig. 2.
The corresponding predicted repeats for members of the
EGFR family are shown in Fig. 3. LRR-like motifs are
most readily identified in the 4th and 5th repeats in the IR
family L1 and EGFR family L2 domains and in the 3rd,
4th and 5th repeats of the IR family L2 and EGFR family
L1 domains. The size of these repeats (22–30 residues) is
similar to the range found in other LRRs (Fig. 1). The 4th
repeat in the L1 and L2 domains of the IR family contain
an insert of 7–8 residues between conserved positions 1
and 2 (Fig. 2), which appears as an extra loop in the 3D
structure [8]. The 4th repeats of the majority of the EGFR
L1 and L2 domains show similar inserts of 6–7 residues
in this region, with the EGFR from Schistosoma manso-
ni (SMEGFRA) and Drosophila melanogaster
(TOP_DROME) having inserts of 11 and 13 residues re-
spectively (Fig. 3). Variable sized insertions are also seen
in some (or all) of the 1st and 2nd repeats of the IR and
EGFR L1 domains and the 1st, 2nd and 6th repeats of the
IR and EGFR family L2 domains.
The nature of the residues in the eight highly conserved
positions of the LRR-like repeats in the L domains of IR
and EGFR are summarised in Table 1. The most com-
monly found residues in the L domains of the IR and
EGFR families are: isoleucine at positions 1 and 3; aspar-
agine at position 4; and leucine at positions 2, 5, 6, 7 and
8. However other non-polar residues, particularly valine,
phenylalanine and cysteine, occur in positions 1–3 and
Figure 1
Comparison of repeat motifs in IR and EGFR family L domains with the sequence motifs of LRR subfamilies. The motifs for
LRR_Typical, LRR_PS type, LRR_bacterial type, LRR_SD22-like, LRR_CC type, LRR_R1 type-a, LRR_R1 type-b are based on
[16], the motifs for the S and T type repeats of small proteoglycans (LRR_PGC) are from [21]. The size of the repeat can vary
by insertions at the positions denoted by the dashes [16]. Also shown is a consensus motif for the pectate lyase superfamily
based on the alignments in Fig. 5 and [26].
conserved position  1   2 3  4  5    6    7    8
LRR_Typical         Lxx LxLxxNx Lxx/ LPxx/ϕ Fxx Lxx/      (22-31)
LRR_RI type         Lxx LxLxxNx Lxxxxϕ xx  Lxxx Lxxxxx/   (28-29)
                             C
LRR_CC type         Lxx LxLxxCxxITDxxϕ xx  Lxxx/Cxx/      (25-27)
                                               L
LRR_SD22-like       Lxx LxLxxNx/Ixx  Ixx  LEx  Lxx/      (21-23)
LRR_PS type         Lxx LxLxxNx LxGx IPxx LGx  Lxx/      (23-25)
LRR_bacterial type  Lxx LxVxxNx Lxx  LPx  LPxx/          (20-22)
LRR_PGC-S           Lxx LxLxxNx Ixx  ϕ Pxx LPxx/          (21-23)
LRR_PGC-T           Lxx LxLxxNx Lxx/ ϕ xxxxFxx  Lxx/      (26-28)
IR family           Ixx/LxIxxNx/Lxx  Lxx  Lxx  Lxx-      (23-42)
EGFR family         Ixx/LxIxxNx/Lxx  Lxx  Lxx  Lxx--     (22-46)
Pectate Lyase       xxx ϕ xϕ xxNx ϕ xx  ϕ xx/ ϕ x   ϕ xx       (23-39)
ϕ  = hydrophobic (A,V,I,L,M,F,Y,W)BMC Bioinformatics (2001) 2:4 http://www.biomedcentral.com/1471-2105/2/4
Figure 2
Leucine-rich repeats in the L1 and L2 domain of members of the insulin receptor family. The sequences were sourced from
SwissProt except for IR_CAEEL which is GENBANK:AF012437. Residues equivalent to conserved positions 1 to 8 in the
sequence motif LxxLxLxxNxLxxLxxLxxLxx are shaded. The INSR_MOUSE is not shown as it differs from INSR_RAT at only
S139Y in the 6th repeat of the L1 domain and S415N in the 4th repeat of the L2 domain, positions that are not conserved in the
LRR motif.
L1 domain
 IRR_CAVPO   VC..PSLDIRSE...VAELRR..LENCS   VVEGHLQILLM(5)EDFRSLSFPHLT   QVTDYLLLFRVYGLESLRDLFPNLA
 IRR_HUMAN   VC..PSLDIRSE...VAELRQ..LENCS   VVEGHLQILLM(5)EDFRGLSFPRLT   QVTDYLLLFRVYGLESLRDLFPNLA
IG1R_HUMAN   ICG.PGIDIRND...YQQLKR..LENCT   VIEGYLHILLI(3)EDYRSYRFPKLT   VITEYLLLFRVAGLESLGDLFPNLT
  IG1R_RAT   ICG.PGIDIRND...YQQLKR..LENCT   VIEGFLHILLI(3)EDYRSYRFPKLT   VITEYLLLFRVAGLESLGDLFPNLT
  INSR_RAT   VC..PGMDIRNN...LTRLHE..LENCS   VIEGHLQILLM(5)EDFRDLSFPKLI   MITDYLLLFRVYGLESLKDLFPNLT
INSR_HUMAN   VC..PGMDIRNN...LTRLHE..LENCS   VIEGHLQILLM(5)EDFRDLSFPKLI   MITDYLLLFRVYGLESLKDLFPNLT
ILPR_BRALA   IC..DSMDIRNR...VSNLRQ..LENCT   VIEGYLQILLI(5)QDYSGLAFPNLV   EITDYFLLYRVRGLTNLSELFPNLA
INSR_AEDAE   VCG..TVDVRNS...PAHLDR..LKDCV   VVEGFVHILLI(5)SSFENYSFPLLT   EITEYLLLFRVNGLKSLRRLFPNLA
MIPR_LYMST   VCG..SVDIRSS...MDNFKL..LENCT   VIEGSLRISLF(4)LDFRHLSFPDLR   EITDYLLMYRVYGLETLSKLFPNLA
INSR_DROME   PCK..SMDIRNM...VSHFNQ..LENCT   VIEGFLLIDLI(3)SPLN.RSFPKLT   EVTDYIIIYRVTGLHSLSKIFPNLS
HTK7_HYDAT   VC(7)TIWLNQN(5)VG.FCQY.LQNCT   CWHGNLVVKST(5)ENFKPY.FPKLR   EITGYLLI.SLCTLKFF.HLFPGLT
  IR_CAEEL   RCG..PIDIRNR(4)IKPQ(16)MVNCT   VVEGSLTISFV(22)EF..ITFPHLR   EITGTLLVFETEGLVDLRKIFPNLR
              1    2 3      5  6    7  8     1   2 3  4     5  6 7  8     1   2 3  4  5  6   7  8
                 (1
st:21-39 residues)           (2
nd:25-42 residues)         (3
rd:24-25 residues)
 IRR_CAVPO   VIRG(7)ALVIFEMPHLRDVGLPALG   AVLHGSVRVEKNQELCHLSTIDWG.   LLQPTPSTNYIVG.NKLG.EECA
 IRR_HUMAN   VIRG(7)ALVIFEMPHLRDVALPALG   AVLRGAVRVEKNQELCHLSTIDWG.   LLQPAPGANHIVG.NKLG.EECA
IG1R_HUMAN   VIRG(7)ALVIFEMTNLKDIGLYNLR   NITRGAIRIEKNADLCYLSTVDWSL   ILD.AVSNNYIVG.NKPPK.ECG
  IG1R_RAT   VIRG(7)ALVIFEMTNLKDIGLYNLR   NITRGAIRIEKNADLCYLSTIDWSL   ILD.AVSNNYIVG.NKPPK.ECG
  INSR_RAT   VIRG(7)ALVIFEMVHLKELGLYNLM   NITRGSVRIEKNNELCYLATIDWSR   ILD.YVEDNYIVL.NKDDNEECG
INSR_HUMAN   VIRG(7)ALVIFEMVHLKELGLYNLM   NITRGSVRIEKNNELCYLATIDWSR   ILD.SVEDNHIVL.NKDDNEECG
ILPR_BRALA   VIRG(7)ALVVFEMLDMQKIGLYSLQ   NITRGSVRIEKNPNLCYLDTIDWSF   IAESGYSNNFIVD.NREE.EECV
INSR_AEDAE   VYPG(7)AMVIYELMHIEEIGLISLM   DITRGGVRIEKNPKLCFANTIDWK.   AMTVPGTNNYIKD.NQKDN.VCP
MIPR_LYMST   IIRG(7)AIVMYEMRDLQDLGLVNLR   TISRGGVRLTKNFKLCYIETINWT.   QIGVSDPEARRFINNK...EQCP
INSR_DROME   VIRG(7)ALVVYSNFDLMDLGLHKLR   SITRGGVRIEKNHKLCYDRTIDWLE   ILAENETQLVVLTENGKE.KECR
HTK7_HYDAT   VIRG(7)ALVIYYN.EIKEVYFPSLT   AILNGGVHIGRNHRLCYVNTIRWKS   IIKD(7)GIYLES.NKL...NCD
  IR_CAEEL   VIGG(7)ALIIYRNPDL.EIGLDKLS   VIRNGGVRIIDNRKLCYTKTIDWKH   LITSSINDVVVD..NAA(9)MCP
             .1      2 3  4  5  6 7  8     1    2 3  4  5  6  7 8      1      2 3   4
                (4
th:29-30 residues)         (5
th:24-25 residues)         (6
th:20-27 residues)
L2 domain
 IRR_CAVPO   ECK(2)TKTIDSVQAAQDLVGCT   HVEG.SLILNLR(2)YNLEPELQRSLGLVE   TITGFLKIKHSFALVSLSFFKNLK
 IRR_HUMAN   ECK(2)TKTIDSIQAAQDLVGCT   HVEG.SLILNLR(2)YNLEPQLQHSLGLVE   TITGFLKIKHSFALVSLGFFKNLK
IG1R_HUMAN   VCE(4)TKTIDSVTSAQMLQGCT   IFKG.NLLINIR(2)NNIASELENFMGLIE   VVTGYVKIRHSHALVSLSFLKNLR
  IG1R_RAT   VCG(5)TKTIDSVTSAQMLQGCT   ILKG.NLLINIR(2)NNIASELENFMGLIE   VVTGYVKIRHSHALVSLSFLKNLR
  INSR_RAT   VCQ(4)TKTIDSVTSAQELRGCT   VING.SLIINIR(2)NNLAAELEANLGLIE   EISGFLKIRRSYALVSLSFFRKLH
INSR_HUMAN   VCH(4)TKTIDSVTSAQELRGCT   VING.SLIINIR(2)NNLAAELEANLGLIE   EISGYLKIRRSYALVSLSFFRKLR
ILPR_BRALA   SCK...GGLVDSLAAAQRFRGCT   IIEG.ELKISIR(2)DNIIDELEENLGLIE   EVGHYVAIVRSYALVTLDFLRSLK
INSR_AEDAE   RCE...GSNIDNIQSAQLLKGCE   IIDG.SLEIQLR(4)ENIVKELENFLSSIT   EIKGYLKVVRSYPLPSLGFLKKLK
MIPR_LYMST   ECH...GLEINNIQDAHKLKECS   KISG.PLKIQIM(2)SNVAQELEKSLGNIR   EVTETIHIKRSYALVTLHFFKNLQ
INSR_DROME   ECS...SGLIDSLERAREFHGCT   IIT(4)LTISIK(4)AHVMDELKYGLAAVH   KIQSSLMVHLTYGLKSLKFFQSLT
HTK7_HYDAT   VCK(15)IRVPSDISKKGLVGCS   VFEG.SLTFQLQ(3)GKAEDSLNE.LKSLK   VLKGHLKIQKS.SLKSLNFLSSLE
  IR_CAEEL   VCE..INHVIDTFPKAQAIRLCN   IIDG.NLTIEIR(4)SGMASELKDIFANIH   TITGYLLVRQSSPFISLNMFRNLR
              1     2 3  5  6  7  8     1    2 3        5   6   7  8     1   2 3  4  5  6  7  8
              (1
st:20-34 residues)           (2
nd:28-32 residues)         (3
rd:23-24 residues)
 IRR_CAVPO   LIRG(8)TLYVLDNQNLQQLG.PWVSAGL   TIPVGKIYFAFNPRLCLEHIYRLEE.VT   GTRGRQNKAEINPRTNGDRAACQT
 IRR_HUMAN   LIRG(8)TLYVLDNQNLQQLG.SWVAAGL   TIPVGKIYFAFNPRLCLEHIYRLEE.VT   GTRGRQNKAEINPRTNGDRAACQT
IG1R_HUMAN   LILG(8)SFYVLDNQNLQQLW.DWDHRNL   TIKAGKMYFAFNPKLCVSEIYRMEE.VT   GTKGRQSKGDINTRNNGERASCES
  IG1R_RAT   LILG(8)SFYVLDNQNLQQLW.DWNHRNL   TVRSGKMYFAFNPKLCVSEIYRMEE.VT   GTKGRQSKGDINTRNNGERASCES
  INSR_RAT   LIRG(8)SFYALDNQNLRQLW.DWNKHNL   TITQGKLFFHYNPKLCLSEIHKMEE.VS   GTKGRQERNDIALKTNGDQASCEN
INSR_HUMAN   LIRG(8)SFYALDNQNLRQLW.DWSKHNL   TITQGKLFFHYNPKLCLSEIHKMEE.VS   GTKGRQERNDIALKTNGDKASCEN
ILPR_BRALA   RIRG(8)AFYVLDNRNLEKLF.DWDRTDI   TIDEGKLFFHFNPKLCRHVILTMVDKVG   LPEHAITDTDISTLTNGDQAQCSF
INSR_AEDAE   IIHG(8)SLYVVENQNLQELF.DH...NV   TIGEGKLFFFNNPMLWTDRIKAVKK.YN   PGIEIENESQLE.SNNGDRAACSI
MIPR_LYMST   IIGS(14)LFLMDNTNLQELFPEEQMKKM   KILNGGIYVHDNGQLCPHTIKEF...LS   HLNLSEAQSSISSISNGHQRPCEK
INSR_DROME   EISG(9)ALYVLDNRDLDELWGPN..QTV   FIRKGGVFFHFNPKLCVSTINQLLPMLA   SKPKFFEKSDVGADSNGNRGSCGT
HTK7_HYDAT   VIET(11)MAVYENSQLSELWPGN..ESI   IVSDGGIFFQYNPRLCPLHIRNLQDRIH   YKNGSKVTGEVSLQNNGHKVLCDT
  IR_CAEEL   RIEA(8)AITVFENPNLKKLFDST..TDL   TLDRGTVSIANNKMLCFKYIKQLMSKLN   .IPL..DPIDQSEGTNGEKAICED
              1      2 3  4  5  6   7    8    1    2 3  4  5    6  7   8     1        3    4
                  (4
th:30-39 residues)           (5
th:25-28 residues)          (6
th:21-24 residues)BMC Bioinformatics (2001) 2:4 http://www.biomedcentral.com/1471-2105/2/4
Figure 3
Leucine-rich repeats in the L1 and L2 domains of members of the epidermal growth factor receptor family. The sequences
were sourced from SwissProt except for SMEGFRA which is from EMBL and CVULET23 which is from GENBANK. Residues
equivalent to conserved positions 1 to 8 in the sequence motif LxxLxLxxNxLxxLxxLxxLxx are shaded.
L1 domain
  ERB2_HUM   VCTGTDMKLRLPAS(4)LDMLRHLYQGCQ   VVQGNLELTYLP.TNA.SLSFLQDIQ   EVQGYVLIAHNQVRQVPLQRLR
  ERB2_RAT   VCTGTDMKLRLPAS(4)LDMLRHLYQGCQ   VVQGNLELTYVP.ANA.SLSFLQDIQ   EVQGYMLIAHNQVKRVPLQRLR
  EGFR_HUM   VCQGTSNKLTQLGT(4)FLSLQRMFNNCE   VVLGNLEITYVQ.RNY.DLSFLKTIQ   EVAGYVLIALNTVERIPLENLQ
EGFR_MOUSE   VCQGTSNRLTQLGT(4)FLSLQRMYNNCE   VVLGNLEITYVQ.RNY.DLSFLKTIQ   EVAGYVLIALNTVERIPLENLQ
EGFR_CHICK   VCQGTNNKLTQLGH(4)FTSLQRMYNNCE   VVLSNLEITYVE.HNR.DLTFLKTIQ   EVAGYVLIALNMVDVIPLENLQ
XMRK_XIPMA   VCQGTSNQMTMLDN..HYLKMKKMYSGCN   VVLENLEITYTQ.ENQ.DLSFLQSIQ   EVGGYVLIAMNEVSTIPLVNLR
  ERB3_HUM   VCPGTLNGLSVTGD(4)YQTLYKLYERCE   VVMGNLEIVLTG.HNA.DLSFLQWIR   EVTGYVLVAMNEFSTLPLPNLR
  ERB4_HUM   VCAGTENKLSSLSD(4)YRALRKYYENCE   VVMGNLEITSIE.HNR.DLSFLRSVR   EVTGYVLVALNQFRYLPLENLR
 TOP_DROME   ICIGTKSRLSVPSN(4)YRNLRDRYTNCT   YVDGNLKLTWLPNENL.DLSFLDNIR   EVTGYILISHVDVKKVVFPKLQ
LT23_CAEEL   LCSGTTNGISRYGT(3)LEDLETMYRGCR   RVYGNLEITWI(24)LKSINFFDNLE   EIRGSLIIYRANIQKISFPRLR
  CVULET23   VCSGTNNLLSRYGS(3)LEDLE.MYRGCR   RVYGNLEITWI(22)LKTVNFFDHLE   EIRGSLIIYRANIQKISFPKLR
   SMEGFRA   ACRVWERDCSKPNP(4)LTYIKFLYGGCT   HIIGNLVICGLE(6)DPDLSFLEKIE   DVSGYVYIGQNSVKTISLPSLK
              1      2 3      5  6   7  8     1   2 3  4    5  6  7  8     1   2 3  4 5  6 7  8
                  (1
st:27-30 residues)           (2
nd:24-46 residues)          (3
rd:22 residues)
  ERB2_HUM   IVRGT(7)ALAVLDN(16)GLRELQLRSLT   EILKGGVLIQRNPQLCYQ.DTILWKD   IFH(6)LTLIDT.NRSRACH
  ERB2_RAT   IVRGT(7)ALAVLDN(17)GLRELQLRSLT   EILKGGVLIRGNPQLCYQ.DMVLWKD   VFR(6)PVDIDT.NRSRACP
  EGFR_HUM   IIRGN(7)ALAVLSNY(6)GLKELPMRNLQ   EILHGAVRFSNNPALCNV.ESIQWRD   IVS(5)NMSMDFQNHLGSCQ
EGFR_MOUSE   IIRGN(7)ALAILSNY(6)GLRELPMRNLQ   EILIGAVRFSNNPILCNM.DTIQWRD   IVQ(5)NMSMDLQSHPSSCP
EGFR_CHICK   IIRGN(7)ALAVLSNY(7)GLRELPMKRLS   EILNGGVKISNNPKLCNM.DTVLWND   IID(5)LTVLDFASNLSSCP
XMRK_XIPMA   LIRGQ(7)TLLVMSN(13)GLKQLQLSNLT   EILSGGVKVSHNPLLCNV.ETINWWD   IVD(5)TMNLIPHAFERQCQ
  ERB3_HUM   VVRGT(7)AIFVMLNY(7)ALRQLRLTQLT   EILSGGVYIEKNDKLCHM.DTIDWRD   IVR(2)DAEIVVKDNGRSCP
  ERB4_HUM   IIRGT(7)ALAIFLNY(7)GLQELGLKNLT   EILNGGVYVDQNKFLCYA.DTIHWQD   IVR(5)NLTLVSTNGSSGCG
 TOP_DROME   IIRG(13)ALFVTYS....KMYTLEIPDLR   DVLNGQVGFHNNYNLCHM.RTIQWSE   IVS(5)YYNYDFTAPERECP
LT23_CAEEL   VIYGD(6)ALYIHKND...KVHEVVMRELR   VIRNGSVTIQDNPKMCYIGDKIDWKE   LLY(3)VQKVETTNSHQHCY
  CVULET23   VIYGD(6)SLYIHQNE...KVNELVMKELR   VIRNGSVSIQNNPRMCFLATKVDWNE   ILY(3)RQKVEXXNSHKACW
   SMEGFRA   VIRG(11)ALVISRN....SLEILDLRSLT   AIQRNDIVALNNQFLCNFGFTIDWEQ   IFE(4)QMFIPDRK(6)ACD
              1       2 3  4     5  6 7  8     1    2 3  4  5  6   7 8      1     2 3   4 5
                  (4
th:30-47 residues)            (5
th:26-27 residues)       (6
th: 19-24 residues)
L2 domain
  ERB2_HUM   VCY.GLGMEH(5)AVTSANIQEFAGCK   KIFGSLAFLPE(11)PLQPEQLQVFETLE   EITGYLYISAWPDSLPDLSVFQNLQ
  ERB2_RAT   VCY.GLGMEH(5)AITSDNVQEFDGCK   KIFGSLAFLPE(11)PLRPEQLQVFETLE   EITGYLYISAWPDSLRDLSVFQNLR
  EGFR_HUM   VCN.GIGIGE(5)SINATNIKHFKNCT   SISGDLHILPV(11)PLDPQELDILKTVK   EITGFLLIQAWPENRTDLHAFENLE
EGFR_MOUSE   VCN.GIGIGE(5)SINATNIKHFKYCT   AISGDLHILPV(11)PLDPRELEILKTVK   EITGFLLIQAWPDNWTDLHAFENLE
EGFR_CHICK   VCN.GIGIGE(5)SINATNIDSFKNCT   KINGDVSILPV(11)PLDPKKLDVFRTVK   EISGFLLIQAWPDNATDLYAFENLE
XMRK_XIPMA   VCD.GIGIGS(5)AVNSTNIRSFSNCT   KINGDIILNRN(11)TMDPEHLWNLTTVK   EITGYLVIMWWPENMTSLSVFQNLE
  ERB3_HUM   AC...EGTGS(5)TVDSSNIDGFVNCT   KILGNLDFLIT(11)ALDPEKLNVFRTVR   EITGYLNIQSWPPHMHNFSVFSNLT
  ERB4_HUM   ACD.GIGTGS(5)TVDSSNIDKFINCT   KINGNLIFLVT(11)AIDPEKLNVFRTVR   EITGFLNIQSWPPNMTDFSVFSNLV
 TOP_DROME   TCP.GVTV......LHAGNIDSFRNCT   VIDGNIRILDQ(19)PLDPERREVFSTVK   EITGYLNIEGTHPQFRNLSYFRNLE
LT23_CAEEL   ICT..VDGH.....LTNETLKNLEGCE   QIDGHLIIEHAF...TYE..QLKVLETVK   IVSEYITIVQQ..NFYDLKFLKNLQ
  CVULET23   ICT..VDGP.....LTNETLKTLEGCE   QIDGHLIIEKKF...KYE..ELKVLETVK   IVSEXITIVEQ..DFFXLKFLKNLQ
   SMEGFRA   HC(4)IFVNG(3)ILQSSSLRKFKSCV   YYTGGLYISKE(11)IQNVNELYNLLHLK   SIVGYIYF(5)PEELKNLTFLENLE
              1   2 3      5    6  7  8     1   2 3        5    6  7  8     1   2 3  4   5  6  7  8
                 (1
st:20-28 residues)            (2
nd:24-44 residues)           (3
rd:23-27 residues)
  ERB2_HUM   VIRGR(7)SLTLQ.GLGISWLGLRSLR   ELGSGLALIHHNTHLCFVHTVPWDQ   LFR(4)ALLHTANRPEDE.CV
  ERB2_RAT   IIRGR(7)SLTLQ.GLGIHSLGLRSLR   ELGSGLALIHRNAHLCFVHTVPWDQ   LFR(4)ALLHSGNRPEEDLCV
  EGFR_HUM   IIRGR(7)SLAVV.SLNITSLGLRSLK   EISDGDVIISGNKNLCYANTINWKK   LFG(4)KTKIISNRGENS.CK
EGFR_MOUSE   IIRGR(7)SLAVV.GLNITSLGLRSLK   EISDGDVIISGNRNLCYANTINWKK   LFG(4)KTKIMNNRAEKD.CK
EGFR_CHICK   IIRGR(7)SLAVV.NLKIQSLGLRSLK   EISDGDIAIMKNKNLCYADTMNWRS   LFA(4)KTKIIQNRNKND.CT
XMRK_XIPMA   IIRGR(7)SFVVVQVRHLQWLGLRSLK   EVSAGNVILKNTLQLRYANTINWRR   LFR(4)SIEYD.ARTEN..QT
  ERB3_HUM   TIGGR(7)SLLIMKNLNVTSLGFRSLK   EISAGRIYISANRQLCYHHSLNWTK   VLR(5)RLDIKHNRPRRD.CV
  ERB4_HUM   TIGGR(6)SLLILKQQGITSLQFQSLK   EISAGNIYITDNSNLCYYHTINWTT   LFS(4)RIVIRDNRKAEN.CT
 TOP_DROME   TIHGR(7)AALAIVKSSLYSLEMRNLK   QISSGSVVIQHNRDLCYVSNIRWPA   IQK(4)KVWVNENLRAD.LCE
LT23_CAEEL   IIEGR(7)ALAIYQCDDLEELSLNSLK   LIKTGAVLIMKNHRLCYVSKIDWSS   IIT(8)SLAIAENRDSK.LCE
  CVULET23   IIEGR(7)ALAIYLCDNLAELXLNSLK   LIRTGSVLIKKNHRLCYVGTVDWES   IIQ(8)NLKVEENRDRK.LCI
   SMEGFRA   VVLEV(7)VITIMNGENIESFGFKSLT   NIG.GYVYLKNMPKLCYISAL.TK.   MLP(2)MIDVQDEE....LCA
              1       2 3  4  5  6  7 8     1    2 3  4  5  6  7 8      1     2 3  4
                 (4
th:30-31 residues)          (5
th:22-25 residues)       (6
th:16-25 residues)BMC Bioinformatics (2001) 2:4 http://www.biomedcentral.com/1471-2105/2/4
5–8 in some sequences (Figs 2 & 3). The most common
alternatives to asparagine at the 4th conserved position
are valine, methionine, serine and tryptophan (Table 1).
The locations of the eight conserved residues in the 3D
structure of IGF-1R L1 domain have been compared with
the location of the equivalent residues in the 3D struc-
tures of the known LRR proteins porcine RI and intern-
alin 1B. As shown in Fig. 4, the 3D structures of the first
part of the repeat (LxxLxLxxNx) are very similar in each
of these proteins (β -strand flanked by two half turns),
while the structures of the remainder of the repeats are
more variable. This is despite the size variability of the
sequence patterns seen in some of the repeats in the L
domains of the IGF-1R and the more frequent occur-
rence of non-L residues at highly conserved positions 1–
3 and 5–8.
The pectate lyase family [24,25] shows even greater var-
iability, with large insertions in some repeats corre-
sponding to loops overlaying the parallel beta helix core
(see Fig. 4). As for other LRRs, the most conserved resi-
dues include positions 2–4, being two aliphatic side
chains and the Asn ladder (Fig. 5). However, at each of
the 8 highly conserved positions, isoleucine or valine is
preferred over leucine [26]. In positions 2 and 3 the fre-
quency of I or V is greater than 60%. The features which
set apart the pectate lyase repeat from that of other LRR
families are an aromatic residue in position 5, extending
the third β -strand and forming a bulge (top left in Figure
4). Residues at positions 7 and 8 slide over to spatially
overlap with positions 6 and 7 in other LRRs.
Discussion
There is considerable interest in the structure of the L
domains of the IR and EGFR families and their relation-
ship with other proteins, because of their importance in
ligand binding (see [8,10,27,28]). In this paper, evidence
is presented to show that these L domains contain all of
the features of leucine-rich repeats. Multiple sequence
alignments, coupled with the 3 D structure of the L1 and
L2 domains of the IGF-1R [8], enabled the residues
equivalent to the conserved residues in known LRR mo-
tifs, to be identified as summarised in Figs 2,3,4.
A variant of the motif LxxLxLxxNx-Lxx-Lxx-Lxx-Lxx-
found in LRR proteins can be identified in the L1 and L2
domains of the IR and EGFR families, where I rather
Table 1: Frequency of occurrence of amino acid residues in the eight conserved positions of the LRR-like motifs in the L domains of the 
IR and EGFR families
Residue IR Family (L1 + L2) EGFR Family (L1 + L2)
1st 2nd 3rd 4th 5th 6th 7th 8th 1st 2nd 3rd 4th 5th 6th 7th 8th
H - 1---- 1 - - - 2 - - 1--
K 2 7---- -- - - 1 2 ----
R - ----1 -- - - 2 - 3 1--
D - ---11 -- - -- 1 1---
E - ----- 1 - - 1 - - ----
N- 9 - 68 -- 2 - - -- 61 ----
Q- - 1 - - 2 - - 1 2 3 3 2 2 - -
S- 1 - 1 2 - - - - - - 1 4 - - - -
T 7 --3-1 1 - - 5 2 4 ---1
P 1 ---1- -- - -------
G 1 2---- -- - - 2 4 ----
A- 1 3 - 1 1 3 - - - 4 2 5 4 5 - -
V 1 7 2 02 61 21 3421 3 3 5 3 52 461 51 36 1 0
I 91 16 95 51 0 2 0 1 3 1 2 57 18 78 31 41 91 6 9
L6 70 15 2 85 80 51 64 6 70 13 3 57 69 46 53
M1 9 2 1 4 3 - 9 1 - 5 5 1 7 5 1 3 -
C 2 6 ----- 2 6 2 4 1 - 2 --- 2 4
F 2 7 13 1 11 4 39 - 10 1 8 - 8 4 28 -
Y1 - 1 - 5 4 1 1 2 1 - 6 1 1 1 -
W 1 ----- 1 3 - -- 8 1 - 2 3
Calculated from conserved positions indicated in Figs 2 & 3.BMC Bioinformatics (2001) 2:4 http://www.biomedcentral.com/1471-2105/2/4
than L is the most common residue at positions 1 and 3.
Other non-polar amino acids frequently occur in some
positions (Table 1, Figs 2 & 3), as found with other LRR
proteins [16,17,21]. The L domains of the IR and EGFR
families contain five full repeats with the 6th partially
truncated. Some sequences have insertions between con-
served positions 1 and 2 and 4 and 5 (Figs 2 & 3), which
complicate the analysis. However the combination of ex-
Figure 4
Comparison of the location of conserved motif residues in the 3D structures of IGF-1R L1 domain and other LRR and β -helix
proteins. The 3D structures are a human, IG1R fragment (PDB: 1IGR, residues 50–143), b, internalin 1B from Listeria monocy-
togenes (PDB: 1D0B, residues 143–241),c, porcine ribonuclease inhibitor (PDB:2BNH, residues 24–148) and d, pectate lyase C
from Erwinia chrysanthemi (PDB:1PEC, residues 86–245). Residues equivalent to conserved positions 1 to 8 in the sequence
motif LxxLxLxxNxLxxLxxLxxLxx are colour coded as follows: position 1: blue; positions 2 & 3: green; position 4: yellow; posi-
tions 5 – 8: red.BMC Bioinformatics (2001) 2:4 http://www.biomedcentral.com/1471-2105/2/4
Figure 5
Structural repeats in the sequences of Erwinia chrysanthemi pectate lyase C (PEC, [11,12]), Bacillus Subtilis pectate lyase (BN8,
[33]) and Aspergillus niger pectin lyase B (QCX, [34]). Alignment is based on a superposition of the three-dimentional struc-
tures, with residues in the sequence motif shaded. Charged residues (boxed) also form part of the motif but have either a com-
pensating buried charge or are solvent exposed.
PEC   18       AVSKT----ATS-MQ--DIVN---IIDAARL(9)  47
BN8   30       SNVYT----VSN-RN--QLVS---ALGKE       48
QCX   20       ASPVY----PTT-TD--ELVS---YLGDN       38
PEC   48   GAYP-LVIT----YTGNED--SLI(16)GVE--IK     85
BN8   49   TNTTPKIIY----IKGTID---MN(56)MVD--IPA   127
QCX   39      EPRVII----LDQTFD---FT(50)PIT--VNS   108
PEC   86   EFTKGITIIG-ANGS--SA--NFG-----IW--IK    108
BN8  128      N-TTIV(4)NAK--VV--GGN-----FQ--IK    148
QCX  109      N-KSIV(4)KGV--IK--GKG-----LR--VVS   130
PEC  109   KSSD-VVVQ---NMR--IG--YLPG(6)MIR--VD    136
BN8  149    SDN-VIIR---NIE--FQ--DAY(21)NIT--IN    189
QCX  131   GAKN-VIIQ---NIA--VT--DINP(7)AIT--VD    159
PEC  137   DSPN-VWVD---HNE--LF---AA(16)AVD--IKG   173
BN8  190   GGTH-IWID---HCT--FNDGSRP(17)QTD--ASN   230
QCX  160   DSDL-VWID---HVT—TA--RIGR--QHIV--LGTS  184
PEC  174   ASN-TVTVS---YNY--IHG--VKK---VGL--DG(6) 201
BN8  231   GAN-YITMS---YNY--YHD--HDK---SSI--F(11) 262
QCX  185   AND-RVTIS---YSL--I(13)HYW---GVY--LDGS  219
PEC  202   GRN--ITYH---HNY--YN--DVNA--RLPL--QR    223
BN8  263   KLK--ITLH---HNR--YK--NIVQ--RAPR--VR    284
QCX  220   NDM--VTLK---GNY--FY--NLSG--RMPK--VQG   242
PEC  224   GGL--VHAY---NNL--YT--NITG--SGLN--VRQ   246
BN8  285   FGQ--VHVY---NNY--YE(9)FSY---AWG--IGK   314
QCX  243   NTL--LHAV---NNL--FH--NFDG--HAFE--IGT   265
PEC  247   NGQ--ALIE---NNW--FEKA-IN----PVT--SR(4) 271
BN8  315   SSK--IYAQ---NNV--IDVPGLSAA-KTIS--VFS   240
QCX  266   GGY--VLAE---GNV--FQD--VNV---VVETPI     287
PEC  272   NFG-TWVLK---GNN--IT(9)ITWT
BN8  241   GGT-ALYDS---GTL--LNG--TQIN
QCX  288   SG--QLFSS(19)NA--FGN--SGSM
consensus  xxx--ϕ xϕ xx-/ Nx--ϕ xx--ϕ xx/   ϕ x--ϕ x-
            1   2 3     4   5    6      7   8BMC Bioinformatics (2001) 2:4 http://www.biomedcentral.com/1471-2105/2/4
amining multiple sequence alignments with the known
3D structure of the IGF-1R allowed the sequence motifs
to be established.
Leucine rich repeat proteins are members of a broader
class of proteins termed solenoid proteins, where the re-
peating structural units in the polypeptide chain form a
continuous superhelix [17]. Solenoid proteins, including
LRRs, show the simplest relationship between sequence
and structure, compared to the more complicated folds
of globular proteins. Thus recognition of such motifs can
provide valuable insights into the predicted structure of
such protein domains [17]. The most conserved structur-
al feature of LRRs is the LxxLxLxxNx region, while the
remainder of the repeat can differ dramatically [15,17] as
illustrated in Fig. 5. The central sequence xLxLx in this
region of the repeat forms a β -strand with successive re-
peats of this β -strand forming a parallel β -sheet on one
side of the LRR module. This corresponds to the second
β -sheet in the L domains of the IGF-1R, which is the
structural counterpart of the β -sheet that forms the inner
face of RI and internalin (Fig. 4). This face is involved in
protein-protein interactions in RI [15], U2 [29] and the
IR family (see [8,10]).
As shown in Fig 4, the first region of the repeat LxxLx-
LxxNx in RI, internalin, the IGF-1R L domains and pec-
tate lyase all adopt similar structural folds, while the
remainder of the repeats are highly variable. Most of the
repeats in the IR and EGFR L domains are between 21
and 30 residues, within the range commonly found in
other LRRs. The inserts are accommodated as loops
which do not, or are unlikely to, perturb the core struc-
ture [8]. Three of the repeats in pectate lyase have large
inserts of 11–17 residues between the 6th and 7th con-
served position (Fig. 5). The major difference between
the 3D structures of RI and internalin versus the L do-
mains of IGF-1R is the absence of the repetitive helix on
the opposite face to the canonical β -sheet in the IGF-1R
L domains and thus a lack of curvature although the L
domains of IGF-1R are capped by α -helices at the N-ter-
minal end and to a lesser extent at the C-terminus [8].
The existence of repeats in the L domains of IR and
EGFR was first reported by Bajaj et al. [30] who de-
scribed five repeats in the region equivalent to 1–119 in
human IR. The subsequent 3D structure determination
of the two L domains in the IGF-1R showed that they
each contain five full and one partial repeat [8].
Conclusion
Here we have shown, using a combination of sequence
analyses and 3D structure comparisons, that variations
of the repeating motif typical of LRRs is present in the L
domains of members of the IR and EGFR subfamilies
and in β -helix proteins. This motif is not obvious, is dif-
ficult to detect with sequence analysis programs and has
not been described previously. Comparison of the 3D
structure of these domains with other protein structures
showed that L domains matched equally well to the pec-
tate lyase family and LRRs such as porcine ribonuclease
inhibitor. We conclude that these three groups should be
considered part of the same LRR superfamily. In the IR
and EGFR subfamilies, isoleucine (or valine) is preferred
over leucine at some positions of the repeat while in β -
helix proteins isoleucine or valine (or occasionally phe-
nylalanine) are always preferred over leucine.
Methods
Multiple Sequence Analysis
The sequence analysis programs used were from the se-
quence analysis software package of the Genetics Com-
puter Group of the University of Wisconsin,
Biotechnology Centre, Madison, Wisconsin, USA. Files
of individual proteins were edited using the Seqed pro-
gram and aligned using Pileup. Final adjustment to these
alignments were made manually as required using Line-
up. Profiles [31,32] were generated from these aligned
sequences using ProfileMake. The SwissProt database
was probed using ProfileSearch and the alignments dis-
played with ProfileSegments. Specific sequences were
analysed using Gap or ProfileGap. Gap weight and
Length weight penalties used were 3.0 and 0.3 respec-
tively unless stated otherwise.
The proteins used to generate these profiles, were the
chondroadherin precursor (CHAD_BOVIN, 10 LRRs),
platelet glycoprotein 1B alpha chain precursor
(GPBA_MOUSE, 8 LRRs), the bone proteoglycan 2 pre-
cursor (PGS2_RABIT, 10 LRRs) and the putative recep-
tor protein tyrosine kinase from Arabidopsis
(TMK1_ARATH, 8 LRRs). Three profiles were generat-
ed: Prf-1 based on the alignment of the 38 single LRRs in
these four proteins; Prf-2 based on the alignment of the
19 tandem repeats of two LRRs from these four proteins
and Prf-4 which was generated from the alignment of
eight sequences, each containing four LRRs in tandem.
The fragments from CHAD_BOVIN and PGS2_RABIT
used in Prf-4 corresponded to repeats 1–4 and 7–10.
Abbreviations
3D, three dimensional; EGF, epidermal growth factor,
EGFR, epidermal growth factor receptor, Fn3, fibronec-
tin type 3; IR, insulin receptor; IGF-1, insulin-like
growth factor 1; IGF-1R, the type I insulin-like growth
factor receptor; IRR, insulin receptor related receptor;
LRR, leucine-rich repeat; RI, ribonuclease inhibitor;
SCOP, structural comparison of proteins; SMART, sim-
ple modular architecture research tool.BMC Bioinformatics (2001) 2:4 http://www.biomedcentral.com/1471-2105/2/4
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